LabCompass

Kathy D. Miller

Medicine · Indiana University

OpenAlex ORCID
Cancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesCancer Genomics and Diagnostics

Publications

749

Citations

25,229

Est. group size

—

Recurring co-author estimate

Active years

50

Publishing since 1977

Research summary
AI-generated

Kathy D. Miller conducts clinical research in medical oncology, focusing on the treatment of breast cancer. Her work spans clinical trials of new drugs and drug combinations for advanced and metastatic breast cancer, biomarker analyses using circulating tumor DNA and tumor cells, and studies of patient outcomes and quality of life across different breast cancer subtypes.

Breast cancer clinical trialsMetastatic and advanced breast cancer therapiesTriple-negative breast cancerLiquid biopsy and tumor biomarkersPatient outcomes and quality of life

Publication activity has been high and generally growing over the past decade, with a notable spike in 2023 and sustained strong output through 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 66.2/year recently
2017: 18 publications172018: 27 publications182019: 13 publications192020: 31 publications202021: 45 publications212022: 17 publications222023: 217 publications217232024: 26 publications242025: 60 publications252026: 11 publications26
Recent publications
Publishes in
  • Journal of Clinical Oncology×63
  • Cancer Research×44
  • Clinical Cancer Research×12
  • Productivity Press eBooks×12
  • Annals of Oncology×11

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile